GSK and Pfizer to appeal Delaware Zantac (NYSE: GSK) decision

Zantac150

Juanmonino/iStock Unpublished via Getty Images

GSK (NYSE:GSK) said it has begun appealing a recent ruling by a Delaware court that allowed tens of thousands of lawsuits in ongoing litigation related to allegations that its burn drug stomach, Zantac, is said to have caused cancer.